Medicamen Biotech Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA2026
EBIT1820
Earning Per Share912
Expenses9392
Net Profit1215
Net Profit Margin1113
Operating Profit Margin1822
Profit Before Tax1618
Dividends Per Share11
Operation Revenue113117

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Medicamen Biotech is 26 as of 11/29/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2019202020202023
Operating Activities41313-6
Investing Activities-15-37-37-6
Financing Activities-4191929
Others0000
Net Cash Flow-14-5-517

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Medicamen Biotech is -6 as of 11/29/2023